A Phase II Trial of CODE + G-CSF in Advanced NSCL

Abstracts/Posters/Presentations:

• Sandler A, Nichols C, Rynard S, Ansari R, Blanke C, Einhorn L: A Phase II Hoosier Oncology Group Trial using CODE Chemotherapy in Patients with Unresectable Stage III or IV Non-Small Cell Lung Cancer (NSCLC) LUN91-2. Proc Am Soc Clin Oncol, 1993.

Manuscripts/Articles:

• Sandler A, Blanke C, Monaco F, Carey MA, Ansari R, Fisher B, Spiridonidis CH, Einhorn L, Nichols C. CODE (cisplatin, vincristine, doxorubicin, etoposide) plus granulocyte colony-stimulating factor in advanced non-small-cell lung cancer: a Hoosier Oncology Group phase II trial. Am J Clin Oncol. 1998 Jun;21(3):294-7. See abstract.